2022 Virtual Introductory Training Course
Pharmacokinetics & Pharmacodynamics
of Protein Therapeutics
- Concepts and Hands-on Exercises -
Bernd Meibohm, University of Tennessee, Memphis, USA
Johan Gabrielsson, MedDoor AB, Gothenburg, Sweden
The 5-day course will introduce participants to basic principles in the pharmacokinetic and pharmacodynamic evaluation of novel protein therapeutics and provide opportunities for hands-on PK/PD analysis exercises. Topics include target-mediated drug disposition, interspecies scaling, first-in human dose selection, model-informed drug development, pediatric pharmacology, drug-drug interactions, and immunogenicity.
Date: April 25-29, 2022
Time: Daily 9:00 am - 2:00 pm US Central Daylight Saving Time
Last updated: January, 17, 2022
Participants of the 9th 'PKPD of Protein Therapeutics' pharmacometric training course 2019
Hand-on exercises and simulations will be performed in demonstrations and as work assignments with simple software tools. There is no prior modeling experience required.
The course has been held annually since 2011 in a 5-day version and since 2016 also in a 3-day version in North America, Europe and Asia. It has been attended by several hundred scientists from large and small pharma (including companies such as Abbvie, Amgen, AstraZeneca/MedImmune, Bayer, Biogen-Idec, Bristol-Myers, Boehringer, Janssen, EMD Serono, Genentech, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Sanofi, and Roche), academic institutions, and major regulatory agencies.
Testimonials from previous participants:
"Good course all around. Lots to digest and good ammunition to take back to project teams and management!"
"This course was really a good opportunity to learn PK-PD of proteins. I will definitely apply the concepts in my research and encourage my peers to attend the course."
"I was very impressed with the course. I was wishing I had attended long ago before I started any work with biologics. My projects would have gone a lot smoother had I had this knowledge earlier. Almost wished it was longer, though that would be difficult, because there was so much to learn!"
"Best course ever!"